VA Nebraska/Western Iowa HCS
Grand Island CBOC
2201 North Broadwell Avenue, Grand Island, NE 68803
VA Nebraska/Western Iowa HCS Grand Island CBOC is a residential facility in Grand Island, NE offering substance use treatment. Buprenorphine and Naltrexone are used for opioid use disorder. It reports accepting no payment.
Licenses and accreditations
- Commission on Accreditation of Rehabilitation Facilities (CARF)Accredited by CARF, an independent nonprofit accreditor of health and human services.
- The Joint CommissionAccredited by The Joint Commission.
Kinds of care
- Substance use treatment
- Treatment for alcohol and drug use.
Settings
- Residential/24-hour residential
- Living at the facility during treatment.
- Short-term residential
- Living at the facility for 30 days or less.
Medications for opioid use
- Buprenorphine used in Treatment
- Buprenorphine is used here.
- Naltrexone used in Treatment
- Naltrexone is used here.
- Accepts clients using MAT but prescribed elsewhere
- Accepts clients whose medication for opioid use is prescribed elsewhere.
- Buprenorphine maintenance
- Buprenorphine continued over time to prevent relapse.
- Prescribes buprenorphine
- Prescribes buprenorphine.
- Prescribes naltrexone
- Prescribes naltrexone.
- Relapse prevention with naltrexone
- Naltrexone to help prevent relapse.
Payment
- Accepted
- No payment accepted: treatment is free to the client.
Who they serve
- Ages served
- Adults, 26 to 64; Seniors, 65 and older; Young adults, 18 to 25.
- Sex
- Female; Male.
- Programs for
- Veterans.
More details this facility reports
- External Opioid Medications Source
- In-network prescribing entity; No formal relationship with prescribing entity.
- Type of Alcohol Use Disorder Treatment
- Accepts clients using medication assisted treatment for alcohol use disorder but prescribed elsewhere; This facility administers/prescribes medication for alcohol use disorder.
- External Source of Medications Used for Alcohol Use Disorder Treatment
- In-network prescribing entity; No formal relationship with prescribing entity.
- Pharmacotherapies
- Acamprosate (Campral®); Buprenorphine (extended-release, injectable); Buprenorphine with naloxone; Buprenorphine without naloxone; Disulfiram; Medication for mental disorders; Naltrexone (oral); Nicotine replacement; Non-nicotine smoking/tobacco cessation.
- Treatment Approaches
- 12-step facilitation; Cognitive behavioral therapy; Motivational interviewing; Relapse prevention; Substance use disorder counseling.
- Facility Operation (e.g., Private, Public)
- Federal Government; U.S. Department of Veterans Affairs.
- Testing
- Breathalyzer or blood alcohol testing; Drug and alcohol oral fluid testing; Drug or alcohol urine screening; Metabolic syndrome monitoring; Testing for Hepatitis C (HCV).
- Transitional Services
- Discharge Planning; Naloxone and overdose education; Outcome follow-up after discharge.
- Recovery Support Services
- Employment counseling or training; Housing services; Mentoring/peer support; Self-help groups.
- Education and Counseling Services
- Family counseling; Group counseling; Individual counseling; Marital/couples counseling; Smoking/vaping/tobacco cessation counseling; Substance use disorder education.
- Medical Services
- Hepatitis A (HAV) vaccination; Hepatitis B (HBV) vaccination.
- Facility Smoking Policy
- Smoking not permitted.
- Facility Vaping Policy
- Vaping not permitted.
- Ancillary Services
- Case management service; Integrated primary care services; Mental health services; Suicide prevention services; Transportation assistance.
Details are as the facility reported them to the public record. Call the facility to confirm services, availability, and coverage before you go. Something wrong here? Report a problem with this listing.